These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4460073)

  • 21. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

  • 22. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
    Pappas BA; Sobrian SK
    Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.
    Mason ST; Angel A
    Psychopharmacology (Berl); 1983; 81(1):73-7. PubMed ID: 6415734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
    Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
    Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
    [No Abstract]   [Full Text] [Related]  

  • 25. Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim.
    Araki H; Kawashima K; Uchiyama Y; Aihara H
    Eur J Pharmacol; 1985 Jul; 113(3):313-8. PubMed ID: 3930265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
    Boldry R; Chang Y; Miller DD; Uretsky NJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of some psychoactive drugs on central monoamine neurons.
    Corrodi H; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 Sep; 1(5):363-8. PubMed ID: 5587552
    [No Abstract]   [Full Text] [Related]  

  • 28. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered response to apomorphine in 6-hydroxydopamine-treated rats.
    Schoenfeld R; Uretsky N
    Eur J Pharmacol; 1972 Jul; 19(1):115-8. PubMed ID: 5048659
    [No Abstract]   [Full Text] [Related]  

  • 30. On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome.
    Modigh K; Svensson TH
    Br J Pharmacol; 1972 Sep; 46(1):32-45. PubMed ID: 4263796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT.
    Waddington JL
    Pharmacol Biochem Behav; 1980 Dec; 13(6):915-7. PubMed ID: 7193877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6-Aminodopamine-induced degeneration of catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 37. Central effects of 6-hydroxydopamine.
    Longo VG
    Behav Biol; 1973 Oct; 9(4):397-420. PubMed ID: 4200735
    [No Abstract]   [Full Text] [Related]  

  • 38. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
    Quattrone A; Samanin R
    Eur J Pharmacol; 1977 Feb; 41(3):336-6. PubMed ID: 837975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of central action of octopamine.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.